Back to list

Prescription only

ALIIBRU

Generic Name
Ibrutinib
Specification
140mg × 120 ແຄບຊູນ
Dosage Form
—
FDD Registration No.
07-LM-01373-25
Valid until
2028-05-14

Prescription only — Information only — no online sales

Description

Ingredients
Ibrutinib 140mg
Indications
Chronic lymphocytic leukemia (CLL), mantle cell lymphoma, Waldenstrom macroglobulinemia and marginal zone lymphoma
Dosage & Administration
Oral administration
Description
ALIIBRU, active ingredient Ibrutinib, capsule, registered in Lao PDR.

Related products

Aliivosidenib
Prescription only

Aliivosidenib

Generic Name:Ivosidenib

Specification:250mg × 60 ເມັດ

Oncology & Hematology

View Details
ALIOLAPARIB
Prescription only

ALIOLAPARIB

Generic Name:Olaparib

Specification:150mg × 120 ເມັດ

Oncology & Hematology

View Details
Osimitib
Prescription only

Osimitib

Generic Name:Osimertinib

Specification:80mg × 30 ເມັດ

Oncology & Hematology

View Details
ALIDABRAFENIB
Prescription only

ALIDABRAFENIB

Generic Name:Dabrafenib

Specification:75mg × 120 ແຄບຊູນ

Oncology & Hematology

View Details
Information only — no online salesDisclaimer & Terms02057111655

Information only — no online sales · Disclaimer & Terms